RECRUITINGN/A

Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)

The aim of this study is the identification of complications in diabetes mellitus pediatric patients and to compare the clinical, anthropometric, and biochemical characteristics between children in the different types of diabetes mellitus.

Sponsor

Hospital Regional de Alta Especialidad del Bajio

Enrollment

500 participants

Sites

1 locations

Start Date

March 2008

Completion

December 2020

Diabetes Mellitus

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

500

participants

Sites

locations

Duration

22.8 years

total trial span

Rate

pts/month needed

Mar 2008Month 220 of 273Dec 2020

81% of trial timeline elapsed53 months to primary endpoint

At 1 sites, each site needs to enroll approximately 2.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus.

Evia-Viscarra María Lola, Guardado-Mendoza Rodolfo, Rodea-Montero Edel RafaelPloS one2017

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGN/A

Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)

Sponsor

Hospital Regional de Alta Especialidad del Bajio

Enrollment

500 participants

Sites

1 locations

Start Date

March 2008

Completion

December 2020

Diabetes Mellitus

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

500

participants

Sites

locations

Duration

22.8 years

total trial span

Rate

pts/month needed

Mar 2008Month 220 of 273Dec 2020

81% of trial timeline elapsed53 months to primary endpoint

At 1 sites, each site needs to enroll approximately 2.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus.

Evia-Viscarra María Lola, Guardado-Mendoza Rodolfo, Rodea-Montero Edel RafaelPloS one2017

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Diabetic retinopathy

year 3

A microvascular complication determined by ophthalmological evaluation

Peripheral diabetic neuropathy

year 5

A microvascular complication determined by neurological exam in either foot

Nerve damage

year 5

A microvascular complication determined by nerve conduction study in either foot

Microalbuminuria

annual

A microvascular complication determined by urine albumin excretion \>= 30 mg/day

Cardiac function

year 5

A cardiovascular risk indicator determined by echocardiogram

Cognitive evaluation

year 3

Determined by scores on the Mini-Mental State Examination

Intelligence quotient evaluation

year 3

Determined by Intelligence quotient test

Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)